We demonstrate a novel route for hierarchical selfassembly of sub-micrometer-sized peptide superstructures that respond to subtle changes in Zn 2+ concentration. The self-assembly process is triggered by a specific folding-dependent coordination of Zn 2+ by a de novo designed nonlinear helix−loop−helix peptide, resulting in a propagating fiber formation and formation of spherical superstructures. The superstructures further form larger assemblies that can be completely disassembled upon removal of Zn 2+ or degradation of the nonlinear peptide. This flexible and reversible assembly strategy of the superstructures enables facile encapsulation of nanoparticles and drugs that can be released by means of different stimuli. Figure 5. (a) Light micrograph and (b) epifluorescence micrograph of superstructures containing p-FTAA. (c) Release of p-FTAA from superstructures over 7 days. Lines are drawn as a guide for the eye.
■ INTRODUCTION
Peptide-directed self-assembly is a versatile tool for fabrication of structurally well-defined functional materials, such as nanoparticles, 1−3 fibers, 4−7 and hydrogels. 8−11 The extraordinary chemical flexibility of peptides, combined with the wellestablished design rules for obtaining defined structural motifs, such as α-helical coiled coils, 12 and the possibilities to include bioactive amino acid sequences, such as RGD and IKVAV for cell adhesion, 13 enables several possibilities to make selfassembling and stimuli-responsive peptide-based materials. The peptide self-assembly process can be triggered and controlled by subtle changes in e.g. pH, 14−16 temperature, 17, 18 and metal ion coordination 19−21 and by specific interactions with complementary peptides or other biomolecules. 22−24 The numerous possibilities to modulate the assembly process have enabled development of a wide range of peptide-based materials for applications in biosensing, 25, 26 drug delivery, 27, 28 and tissue engineering. 29, 30 Metal cations are attractive modulators of peptide-directed self-assembly since peptides can coordinate certain cations with high specificity and affinity. 31 Yet, the interactions are reversible, and the bound metal ions can be removed by competing ligands showing higher metal ion affinities, including common chelating agents such as ethylenediaminetetraacetic acid (EDTA), citrate, and phytic acid 32 and serum components such as albumin. Zn 2+ is one of the most frequently found metal cations in metalloproteins, for instance found in DNA binding zinc finger motifs, 33 and as well in numerous enzymes including carbonic anhydrases, metalloproteinases, and carboxypeptidases. 34 In addition to the catalytic role of Zn 2+ in metalloenzymes, its prevalence in proteins stems from its extraordinary ability to coordinate to many different amino acids (e.g., glutamic acid, aspartic acid, and histidine) due to its flexible coordination geometries. 35 Numerous other biomolecules and drugs, such as vitamin B 9 , acetylsalicylic acid, and nucleotides, do also interact with Zn 2+ . 36−38 The possibility to exploit Zn 2+ −peptide interactions is thus an attractive route both to control peptide folding and to tailor the properties of responsive peptide-based materials and nanostructures and for fabrication of various supramolecular hybrid materials.
In this paper we investigate a novel strategy to hierarchically self-assemble peptide superstructures using Zn 2+ -triggered folding of a de novo designed helix−loop−helix polypeptide ( Figure 1a ). In the presence of Zn 2+ the peptides fold and selfassemble into spherical superstructures that gradually grow into larger fibrous assemblies. The process depends on the folding of the polypeptides and is fully reversible as complete disassembly occurs upon removal of the Zn 2+ . Since numerous compounds, including drugs and functionalized nanoparticles, also can coordinate Zn 2+ , they can be encapsulated in the superstructures with high efficiency if present during the assembly process. The possibility to trigger the disassembly of the peptide superstructures offers means to control the release rate of encapsulated species. The specific folding-dependent interactions modulated by peptide coordination of Zn 2+ thus offers routes for fabrication of dynamic and stimuli-responsive soft nanostructured materials with defined and tunable properties and a novel strategy for encapsulation and release of drugs.
■ EXPERIMENTAL DETAILS
General. Amino acids and chemicals for peptide synthesis were acquired from Iris Biotech GmbH (Germany). The oligothiophene p-FTAA 39 was kindly provided by the group of Peter Nilsson at Linkoping University. All other chemicals were acquired from Sigma-Aldrich (Sweden). All experiments were conducted in Bis-Tris buffer (30 mM, pH 7) at room temperature if nothing else is stated.
Synthesis and Purification of Peptides. JR2EC, JR2E, and D-Ala-JR2EC (peptide identity and sequences in the Supporting Information) were synthesized using Fmoc strategy and sequentially purified as described previously. 26 Linking two peptides via a disulfide bridge was carried out by dissolving peptides (2 mg/mL) in ammonium hydrogen carbonate buffer (10 mM, pH 8.5), and subsequent incubation for 72 h at room temperature on an orbital shaker. Formation of the disulfide bridge was confirmed by an Ellman's test of free thiols. 40 The linked peptides were then diluted with 2-fold of double-filtered distilled water, rotary evaporated twice, and sequentially lyophilized to a dry powder.
Gold Nanoparticle Functionalization. JR2EC functionalized AuNPs (40 nm in radius) were synthesized as described previously. 26 AuNPs (∼70 nM, BBI Solutions, UK) were incubated with 10 μM JR2EC (10 mM sodium citrate, pH 6) at 4°C overnight. After incubation the particles were repeatedly centrifuged (12000g, 30 min), and the buffer subsequently exchanged with Bis-Tris buffer (30 mM, pH 7) until the concentration of unbound JR2EC was below 5 pM. The concentration of JR2EC-AuNP was calculated using an extinction coefficient of 1.03 × 10 10 M −1 cm −1 . 41 Folding of Polypeptides. The secondary structures of JR2EC 2 and D-Ala-JR2EC 2 were investigated by circular dichroism (CD) spectroscopy with a Chirascan spectropolarimeter from Applied Photophysics (UK). CD spectra were acquired between 190 and 250 nm at 20°C with a resolution of 0.5 nm. Each sample was incubated in Bis-Tris buffer (30 mM, pH 7) with desired Zn 2+ concentration (0−2 mM) at room temperature for 30 min prior to measurement. The ratio of the ellipticities at 222 and 208 nm was calculated to compare the difference in helicity of JR2EC 2 and D-Ala-JR2EC 2 . 42 Formation of Superstructures. If nothing else is stated, JR2EC 2 (50 μM) was incubated with Zn 2+ (4 mM) in Bis-Tris buffer (30 mM, pH 7) for 24 h. In encapsulation studies with Rhodamine-B and p-FTAA, 10 μM of the desired compound was added prior to Zn 2+ as well. In encapsulation studies with JR2EC-AuNPs, 0.40 nM was added prior to Zn 2+ . Formed superstructures with encapsulated compounds were thoroughly washed by three rounds of centrifugation (2000g, 30 s) to remove nonencapsulated compounds. The supernatant was removed in each round of centrifugation, and the formed pellet was resuspended in Bis-Tris buffer with 4 mM Zn 2+ .
Imaging of Assemblies. Optical and Epifluorescence Microscopy. Optical micrographs were acquired with an Eclipse TI microscope from Nikon (Japan). Epifluorescence micrographs of samples containing Rhodamine-B and p-FTAA were acquired using fluorescence filter cubes (Rhodamine-B: ex 528−553 nm; em 590− 650 nm; p-FTAA: ex 400−440 nm, em 470−∞ nm).
Scanning Electron Microscopy. Scanning electron micrographs were acquired with a LEO 1550 Gemini from Zeiss (Germany) operating at 3 kV. Samples were centrifuged (2000g, 30 s), and the formed pellet was put onto conductive carbon tabs. The samples were air-dried overnight at room temperature and sputter coated with a thin layer of tungsten prior to measurement.
Transmission Electron Microscopy. Transmission electron micrographs were acquired with a Tecnai G2 F20 Ultra-Twin microscope from Fei (USA) operating at 200 kV. Preformed samples were incubated on carbon-coated TEM grids for 10 min, and excess liquid was sequentially wicked away using filter paper. Samples were air-dried overnight prior to measurement.
Photographs were acquired with a Nikon D7000 digital camera. Turbidity Measurements. Turbidity measurements were performed by monitoring the absorbance at 340 nm with a FLUOstar galaxy microplate reader from BMG Labtech (Germany).
Dynamic Light Scattering. Dynamic light scattering experiments were performed with an ALV/DLS/SLS-5022F system from ALV-GmbH (Germany). The He−Ne laser was operated at 632.8 nm, and the scattered light was detected perpendicular to the incident laser beam. Peptides and buffers were filtered through a 0.22 μm low protein binding filter prior to measurements. All presented correlation functions are an average of at least five consecutive measurements of 30 s each.
UV−Vis. UV−vis spectra of samples with encapsulated JR2EC-AuNPs were recorded using a UV-2450 spectrophotometer from Shimadzu (Japan).
Release Studies of the Oligothiophene p-FTAA. JR2EC 2 (50 μM), Zn 2+ (4 mM), and p-FTAA (10 μM) were incubated in 1 mL of Bis-Tris buffer (30 mM, pH 7) for 24 h. The formed superstructures with encapsulated p-FTAA were thoroughly washed by three rounds of centrifugation (2000g, 30 s) to remove nonencapsulated p-FTAA. In the last washing step, 1 mL of Bis-Tris buffer containing 0−1.5 mM Zn 2+ was added, and samples were left to incubate on an orbital shaker. At each measurement time point, the sample was centrifuged (2500g, 60 s), and 10 μL aliquots of the supernatant were sampled. The remaining sample was sequentially vortexed and left for further incubation. After 7 days, EDTA was added to the sample to induce complete release of p-FTAA. Each sampled 10 μL aliquot was diluted 1:100 with EDTA (5 mM) solution to chelate all Zn 2+ prior to the fluorescence measurement. Fluorescence emission spectra of collected samples were recorded between 430 and 700 nm (excitation 400 ± 5 nm) with an Infinite M1000 Pro plate reader from Tecan (Switzerland). The intensity at 539 nm for each spectrum was normalized to spectra where 5 mM EDTA had been added to the sample to estimate the cumulative release of p-FTAA.
■ RESULTS AND DISCUSSION
The 42 amino acid residue helix−loop−helix peptide JR2EC is designed to fold and homodimerize into four-helix bundles at acidic pH 43 and at neutral pH in the presence of millimolar concentrations of Zn 2+ . 44 JR2EC has a Cys residue in the loop region, and the linking of two peptide monomers by a disulfide bridge (JR2EC 2 ) results in self-assembly of micrometer long fibers at acidic pH as a result of peptide folding and a propagating homoassociation when the intra-and intermolecular charge repulsion is reduced upon protonation of Glu residues. 43 The possibility to control the peptide self-assembly process at physiological pH using Zn 2+ coordination would, however, be very attractive. The oxidation of JR2EC did not affect the Zn 2+ -induced folding of the peptides at pH 7 ( Figure  1b) . Furthermore, addition of Zn 2+ (4 mM) to a solution of JR2EC 2 (50 μM) resulted in a rapid and dramatic increase in turbidity. In contrast to the formation of extended fibers at acidic pH, 43 addition of Zn 2+ at neutral pH instead induced formation of small spherical particles of about 100−200 nm in radius as seen in scanning electron micrographs ( Figure 1c ) and which further formed larger fibrous assemblies (Figure 1d ). We hypothesize that Zn 2+ initiates the folding and homodimerization of the peptides and a propagating self-assembly of short fibers. Because of the excess amount of Zn 2+ , lateral fiber−fiber interactions cause the fibers to associate into spherical superstructures that in a diffusion-limited aggregation process form the larger assemblies.
To verify that this hierarchical self-assembly process was the result of specific peptide folding mediated interactions and fiber formation, we synthesized a second peptide where the Cys residue was replaced by a Val (JR2E) and a third peptide with the identical primary sequence as JR2EC but where all L-Ala residues were replaced by its enantiomer D-Ala (D-Ala-JR2EC 2 ). Whereas JR2E cannot be oxidized and hence not assemble into fibers, the D-Ala in D-Ala-JR2EC 2 prevents the peptide from folding into four-helix bundles (Figure 2a and Supporting Information Figure S1 ).
The three peptides were subjected to Zn 2+ , and the turbidity (absorbance at 340 nm, A 340 ) was monitored. Only JR2EC 2 showed an increase in turbidity (Figure 2b ), suggesting that neither JR2E nor D-Ala-JR2EC 2 was able to form assemblies large enough to scatter significant amount of light. The increase in turbidity of JR2EC 2 could clearly be seen by the eye, indicating formation of macroscopic assemblies. Solutions of JR2E and D-Ala-JR2EC 2 remained clear even after more than 30 days of incubation (Figure 2c ). Furthermore, dynamic light scattering experiments showed no significant increase in lag times in the autocorrelation functions for neither JR2E nor D-Ala-JR2EC 2 upon addition of Zn 2+ ( Figure S2 ). In contrast, JR2EC 2 displayed a dramatic decrease in solution dynamics, indicating formation of large assemblies. It is thus evident from these results that the peptides must be capable of folding into four-helix bundles and have the capacity to assemble into fibers to form the superstructures when subjected to Zn 2+ .
To examine the critical amount of Zn 2+ required to induce this hierarchical assembly process, we measured the turbidity over 24 h after addition of different concentration of Zn 2+ to JR2EC 2 (50 μM) (Figure 3a ). At 0.5 mM Zn 2+ (1:10 ratio of JR2EC 2 :Zn 2+ ) no increase in turbidity could be seen, although JR2EC 2 was almost fully folded at this Zn 2+ concentration (Figure 2a ). This suggests that lateral fiber−fiber interactions are also needed, in addition to the self-assembly process taking place in the fiber direction, in order to form the superstructures. At slightly higher concentrations of Zn 2+ (1 and 1.5 mM) , an initial increase in turbidity was seen, indicating formation of superstructures. However, these superstructures were not stable and disassembled over time. At Zn 2+ concentrations of 2 mM (1:40 ratio of JR2EC 2 :Zn 2+ ) and above, the turbidity increased steadily over time until a maximum was reached, indicating that stable superstructures had been formed. Moreover, the assembly process was rapid as 50% of the maximum turbidity was reached within 10 min, and 90% was reached within 1−3 h.
As a critical Zn 2+ concentration was needed to form the superstructures, we examined if it was possible to controllable disassemble them after formation by changing the Zn 2+ concentration. Decreasing the concentration of Zn 2+ in the solution increased the disassembly rate of the superstructures and by varying the Zn 2+ concentration this rate could be tuned (Figure 3b ). Reducing the Zn 2+ concentration in solution to 0 mM led to full disassembly within 12 h. The disassembly process was fairly linear with time ( Figure S3a) , and by plotting the disassembly rate versus the Zn 2+ concentration an exponential behavior could be seen ( Figure S3b ). Furthermore, we examined the possibility to disassemble the superstructures by addition of EDTA that chelates Zn 2+ with high affinity (log K = 16.15). 45 The superstructures disassembled almost instantaneously upon addition of EDTA ( Figure S4 and Movie S1). By subsequent addition of Zn 2+ , it was possible to reassemble the superstructures to some extent, showing the reversibility of the system. By varying the concentration of Zn 2+ , it is thus possible to control both the assembly and disassembly rate, and as well the reassembly, of the superstructures.
The disulfide bridge in JR2EC 2 was obviously critical for obtaining the superstructures, and disulfide bridges can be reduced by numerous reducing agents, such as tris(2-carboxyethyl)phospine (TCEP). 46 To test if it was possible to disassemble the superstructures by reduction of the disulfide bridge in JR2EC 2 , we added different concentrations of TCEP to preformed superstructures and monitored the change in turbidity over 24 h. Although TCEP has some minor tendencies to chelate Zn 2+ , the affinity is significantly lower than for EDTA (log K = 2.47). 47 Furthermore, by keeping the concentration of TCEP low enough in the experiment, the effect on the Zn 2+ concentration on the stability of the superstructures will be marginal in comparison to the reduction of the disulfide bridge. By monitoring the turbidity over 24 h, it could clearly be seen that TCEP effectively degraded the superstructures (Figure 3c ), indicating that the individual fibers constituting the superstructures were reduced into single fourhelix bundles. Furthermore, the TCEP-mediated degradation of the superstructures was also rapid and concentration dependent.
Since it was possible to control both the assembly and the disassembly process of the superstructures, we envisioned that it also would be possible to encapsulate different species and to tune their release. As an initial test, gold nanoparticles (40 nm diameter) functionalized with JR2EC (JR2EC-AuNPs) were added to a sample of JR2EC 2 prior to addition of Zn 2+ . The possibility to encapsulate AuNPs in a well-defined peptide material is of great interest in e.g. biosensing applications, enabling e.g. colorimetric monitoring of proteolytic processes. 48 The resulting superstructures had a pink hue, indicating that JR2EC-AuNPs were successfully encapsulated (Figure 4a ). 49 The homogeneous encapsulation of JR2EC-AuNPs was further confirmed by transmission electron microscopy (Figure 4b ). Addition of EDTA triggered the release of the encapsulated JR2EC-AuNPs, resulting in a blue-shift (19 nm) of the localized surface plasmon (LSPR) band as the particles were resuspended (Figure 4c) .
To investigate the possibility to also encapsulate molecular compounds, two different fluorescent molecules, Rhodamine B (RhoB) and the thiophene-based conjugated oligomer p-FTAA ( Figure S5 ), 39 were added prior to addition of Zn 2+ . Both compounds contain carboxyl groups that can interact with Zn 2+ . Whereas RhoB was used as a model system, p-FTAA has recently been shown to significantly reduce the toxicity of prions and amyloid-β peptides, and finding means to improve the pharmacokinetics by controlled release is thus of great interest. 51−53 Both RhoB and p-FTAA were encapsulated in the superstructures (Figure 5a,b and Figure S6 ) and could be released by addition of EDTA ( Figure S7 and Movie S2). The encapsulation efficiency of RhoB was significantly lower as compared to p-FTAA (0.4% compared to 75%; see Table S1 ), which is likely due to the lower amount of carboxyl groups in RhoB as compared to p-FTAA. In addition, p-FTAA is designed to effectively bind to divalent metal ion containing fibrous structures such as amyloid plaques. 54 Because of the low encapsulation efficiency of RhoB, only p-FTAA was used for further release studies.
To further investigate the possibility to control the release rate of encapsulated compounds over an extended period of time, we dispersed p-FTAA loaded superstructures in solutions with different concentrations of Zn 2+ (0−1.5 mM) and studied the cumulative release over 7 days (Figure 5c ). Without Zn 2+ in the solution, roughly 50% of the p-FTAA had been released within 30 min and more than 90% had been released within 24 h. However, with 0.5 mM Zn 2+ in the solution a much slower release profile could be seen. 50% had been released within the first 6 h, but only 70% of the p-FTAA had been released after 7 days. Superstructures dispersed in 1 mM Zn 2+ had an even slower release profile, with roughly 30% p-FTTA release after 7 days, whereas superstructures dispersed in 1.5 mM Zn 2+ showed no significant release of p-FTAA within the measured time span.
■ CONCLUSIONS
In conclusion, we have shown that a Zn 2+ -triggered propagating folding-mediated association of the nonlinear peptide JR2EC 2 results in formation of sub-micrometer-sized fibrous assemblies composed of spherical superstructures. The resulting superstructures can be reversibly assembled and disassembled by adjusting the concentration of Zn 2+ or by reducing the disulfide bridge in JR2EC 2 . Both nanoparticles and drugs could be efficiently encapsulated in the superstructures, and the release rate could be modulated by the Zn 2+ concentration. The possibility to tune both the peptide self-assembly process and the release of compounds by means of different stimuli makes this system an attractive candidate in both drug delivery and bioanalytical applications.
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